J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. Coebergh et al., Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012, European Journal of Cancer, vol.49, issue.6, pp.1374-403, 2013.
DOI : 10.1016/j.ejca.2012.12.027

M. Santoni, R. Berardi, C. Amantini, L. Burattini, D. Santini et al., Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor, International Journal of Cancer, vol.11, issue.12, pp.2772-2779, 2014.
DOI : 10.1002/ijc.28503

A. Tahiri, K. Roe, A. Ree, R. Wijn, . De et al., Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma, PLoS ONE, vol.18, issue.8, pp.1-12, 2013.
DOI : 10.1371/journal.pone.0072692.s006

A. Sikkema, S. Diks, W. Den-dunnen, A. Ter-elst, F. Scherpen et al., Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery, Cancer Research, vol.69, issue.14, pp.5987-95, 2009.
DOI : 10.1158/0008-5472.CAN-08-3660

A. Ree, K. Flatmark, M. Saelen, S. Folkvord, S. Dueland et al., Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: Opportunities for signaling-adapted therapies, Critical Reviews in Oncology/Hematology, vol.95, issue.1, pp.114-138, 2015.
DOI : 10.1016/j.critrevonc.2015.01.003

J. Anderson, D. Minnich, M. Dobelbower, A. Denton, A. Dussaq et al., Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine, PLoS ONE, vol.41, issue.12, 2014.
DOI : 10.1371/journal.pone.0116388.s002

S. Folkvord, K. Flatmark, S. Dueland, R. De-wijn, K. Grøholt et al., Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Multiplex Kinase Activity Profiling, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.2, pp.555-62, 2010.
DOI : 10.1016/j.ijrobp.2010.04.036

J. Anderson, C. Willey, A. Mehta, K. Welaya, D. Chen et al., High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes, PLOS ONE, vol.97, issue.16, 2015.
DOI : 10.1371/journal.pone.0139267.s006

L. Galluzzi, L. Senovilla, L. Zitvogel, and G. Kroemer, The secret ally: immunostimulation by anticancer drugs, Nature Reviews Drug Discovery, vol.107, issue.3, pp.215-248, 2012.
DOI : 10.1038/nrd3626

T. Powles, S. Chowdhury, M. Bower, N. Saunders, L. Lim et al., The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer, Urologia Internationalis, vol.86, issue.1, pp.53-62, 2011.
DOI : 10.1159/000319498

O. Adotevi, H. Pere, P. Ravel, N. Haicheur, C. Badoual et al., A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients, Journal of Immunotherapy, vol.33, issue.9, pp.991-999, 1997.
DOI : 10.1097/CJI.0b013e3181f4c208

P. Autissier, C. Soulas, T. Burdo, and K. Williams, Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans, Cytometry Part A, vol.341, pp.410-419, 2010.
DOI : 10.1002/cyto.a.20859

D. Giorgi, U. Rihawi, K. Aieta, M. Lo-re, G. Sava et al., Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer, Journal of Geriatric Oncology, vol.5, issue.2, pp.156-63, 2014.
DOI : 10.1016/j.jgo.2014.01.001

D. Keizman, M. Ish-shalom, P. Huang, M. Eisenberger, A. Templeton et al., Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy, Eur Urol, vol.70, pp.358-64, 2016.

M. Krusch, J. Salih, M. Schlicke, T. Baessler, K. Kampa et al., The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro, The Journal of Immunology, vol.183, issue.12, pp.8286-94, 1950.
DOI : 10.4049/jimmunol.0902404

A. Guislain, J. Gadiot, A. Kaiser, E. Jordanova, A. Broeks et al., Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.211, issue.10, pp.1241-50, 2015.
DOI : 10.1007/s00262-015-1735-z

H. Huang, E. Langenkamp, M. Georganaki, A. Loskog, P. Fuchs et al., VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-KB-induced endothelial activation, FASEB J Off Publ Fed Am Soc Exp Biol, vol.29, pp.227-265, 2015.

O. Draghiciu, H. Nijman, B. Hoogeboom, T. Meijerhof, and T. Daemen, Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-speci fi c immune responses and tumor eradication, OncoImmunology, vol.4, pp.1-11, 2015.

N. Twine, J. Stover, B. Marshall, G. Dukart, M. Hidalgo et al., Diseaseassociated Expression Profiles in Peripheral Blood Mononuclear Cells from Patients with Advanced Renal Cell Carcinoma, Cancer Res, vol.63, pp.6069-75, 2003.

E. Noessner, D. Brech, A. Mendler, I. Masouris, R. Schlenker et al., T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma, OncoImmunology, vol.1, issue.8, pp.1451-1454, 2012.
DOI : 10.1016/j.intimp.2010.07.002

E. Tartour, H. Pere, B. Maillere, M. Terme, N. Merillon et al., Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy, Cancer and Metastasis Reviews, vol.8, issue.Suppl 10, pp.83-95, 2011.
DOI : 10.1007/s10555-011-9281-4

T. Voron, O. Colussi, E. Marcheteau, S. Pernot, M. Nizard et al., T cells in tumors, The Journal of Experimental Medicine, vol.212, issue.2, pp.139-187, 2015.
DOI : 10.1002/ijc.26094

C. Harmon, S. Deprimo, R. Figlin, G. Hudes, T. Hutson et al., Circulating proteins as potential biomarkers of sunitinib and interferon-?? efficacy in treatment-na??ve patients with metastatic renal cell carcinoma, Cancer Chemotherapy and Pharmacology, vol.108, issue.2, pp.151-61, 2014.
DOI : 10.1007/s00280-013-2333-4

A. Macfarlane, M. Jillab, E. Plimack, G. Hudes, R. Uzzo et al., PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection, Cancer Immunology Research, vol.2, issue.4, pp.320-351, 2014.
DOI : 10.1158/2326-6066.CIR-13-0133

D. Boraschi, M. Aguado, C. Dutel, J. Goronzy, J. Louis et al., The Gracefully Aging Immune System, Science Translational Medicine, vol.5, issue.185, 2013.
DOI : 10.1126/scitranslmed.3005624

C. Lages, I. Lewkowich, A. Sproles, M. Wills-karp, and C. Chougnet, Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1

R. Roskoski, Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor, Biochemical and Biophysical Research Communications, vol.356, issue.2, pp.323-331, 2007.
DOI : 10.1016/j.bbrc.2007.02.156

M. Karaman, S. Herrgard, D. Treiber, P. Gallant, C. Atteridge et al., A quantitative analysis of kinase inhibitor selectivity, Nature Biotechnology, vol.50, issue.1, pp.127-159, 1038.
DOI : 10.1038/nbt1358

Y. Gu, W. Zhao, F. Meng, B. Qu, X. Zhu et al., Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice, Clinical Immunology, vol.135, issue.1, pp.55-62, 2010.
DOI : 10.1016/j.clim.2009.11.013

N. Longo, X. Wang, R. Wildin, and K. Abraham, Regulation of Src-family protein tyrosine kinase transcription during lymphocyte ontogeny, Molecular Immunology, vol.36, issue.15-16, pp.979-92, 1999.
DOI : 10.1016/S0161-5890(99)00134-0

N. Chetoui, M. Boisvert, M. Bergeron, M. Aoudjit, and F. , Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway, Journal of Cellular Biochemistry, vol.343, issue.12, pp.3666-74, 2011.
DOI : 10.1002/jcb.23300

B. Escudier, C. Porta, M. Schmidinger, F. Algaba, J. Patard et al., Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up??, Annals of Oncology, vol.25, issue.suppl 3, pp.49-56, 2014.
DOI : 10.1093/annonc/mdu259

M. Chartier, T. Chénard, J. Barker, and R. Najmanovich, Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree, PeerJ, vol.41, issue.5600, pp.126-136, 2013.
DOI : 10.7717/peerj.126/supp-1